Short Interest in NanoViricides Inc (NYSEAMERICAN:NNVC) Drops By 92.3%

Share on StockTwits

NanoViricides Inc (NYSEAMERICAN:NNVC) was the target of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 11,300 shares, a decline of 92.3% from the August 30th total of 146,700 shares. Based on an average daily trading volume, of 32,300 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.4% of the shares of the company are short sold.

Shares of NYSEAMERICAN:NNVC opened at $1.75 on Friday. NanoViricides has a fifty-two week low of $1.27 and a fifty-two week high of $13.60.

NanoViricides Company Profile

NanoViricides, Inc, a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as injectable and oral anti-influenza nanoviricide drug for H7N9, Bird Flu H5N1, other Highly Pathogenic Influenzas, Epidemic Influenzas, and Seasonal Influenzas; DengueCide, an anti-dengue nanoviricide which is in pre-clinical development; and HIVCide, an anti-human immunodeficiency virus drug candidate.

Recommended Story: How does inflation affect different investments?

Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with MarketBeat.com's FREE daily email newsletter.